Literature DB >> 7794731

Approval of cysteamine for patients with cystinosis.

J A Schneider.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7794731     DOI: 10.1007/bf00860767

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  7 in total

1.  Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusion.

Authors:  Meredith C Fidler; Bruce A Barshop; Jon A Gangoiti; Reena Deutsch; Michael Martin; Jerry A Schneider; Ranjan Dohil
Journal:  Br J Clin Pharmacol       Date:  2007-01       Impact factor: 4.335

2.  Peer Support and Mentorship in a US Rare Disease Community: Findings from the Cystinosis in Emerging Adulthood Study.

Authors:  Maya Doyle
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

Review 3.  The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.

Authors:  Stephanie Cherqui; Pierre J Courtoy
Journal:  Nat Rev Nephrol       Date:  2016-12-19       Impact factor: 28.314

4.  Cystinosin is a Component of the Vacuolar H+-ATPase-Ragulator-Rag Complex Controlling Mammalian Target of Rapamycin Complex 1 Signaling.

Authors:  Zuzanna Andrzejewska; Nathalie Nevo; Lucie Thomas; Cerina Chhuon; Anne Bailleux; Véronique Chauvet; Pierre J Courtoy; Marie Chol; Ida Chiara Guerrera; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 10.121

5.  Nephropathic cystinosis associated with cardiomyopathy: a 27-year clinical follow-up.

Authors:  Mehul P Dixit; Ira Greifer
Journal:  BMC Nephrol       Date:  2002-11-09       Impact factor: 2.388

6.  That eagle covering me: transitioning and connected autonomy for emerging adults with cystinosis.

Authors:  Maya Doyle; Allison Werner-Lin
Journal:  Pediatr Nephrol       Date:  2014-08-27       Impact factor: 3.714

Review 7.  Hematopoietic Stem Cell Gene Therapy for Cystinosis: From Bench-to-Bedside.

Authors:  Stephanie Cherqui
Journal:  Cells       Date:  2021-11-23       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.